BIOMAT Database Logo BIOMAT Database Logo

[Effect of obzidan on cell membrane permeability in myocardial infarct patients]. 1985

A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts

Related Publications

A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Experience with using obzidan in myocardial infarct].
March 1984, Klinicheskaia meditsina,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Effectiveness of obzidan in patients with a history of myocardial infarct].
March 1988, Vrachebnoe delo,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Use of obzidan in the acute period of myocardial infarct].
October 1980, Kardiologiia,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Effect of obzidan and nitroglycerin on heart chamber function in acute myocardial infarct (based on echocardiographic data)].
January 1985, Sovetskaia meditsina,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Pharmacodynamic characteristics of a test using intravenous obzidan administration in patients with myocardial infarct].
December 1988, Vrachebnoe delo,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Effect of obzidan on the adenine nucleotide content of various areas of the heart in experimental myocardial infarct].
January 1987, Farmakologiia i toksikologiia,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Effect of obzidan on coronary blood flow in patients with the hyperkinetic type of hemodynamics in the acute period of myocardial infarct].
August 1988, Kardiologiia,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Obzidan inhibition of lipid free-radical peroxidation in coronary-occluding myocardial infarct].
January 1983, Farmakologiia i toksikologiia,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Effect of diprazine and dimedrol on the vascular permeability in experimental myocardial infarct].
January 1968, Farmakologiia i toksikologiia,
A N Parkhomenko, and V Z Netiazhenko, and P A Angelutsa
[Peripheral circulatory and tissue oxygen regimen functions in acute myocardial infarct patients being treated with obzidan].
February 1986, Vrachebnoe delo,
Copied contents to your clipboard!